OCT 29, 2019 08:00 AM PDT

Multi-omics Approach to Understanding PD-L1 Resistance in Cancer

SPONSORED BY: Sony Biotechnology
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Instructor in Medicine and the Director of the Translational Cancer Immunology lab - Massachusetts General Hospital Cancer Center
    Biography
      Moshe Sade Feldman (PhD) is an Instructor in Medicine and the Director of the Translational Cancer Immunology lab at Massachusetts General Hospital Cancer Center. His research focus is the development of new, unbiased strategies to understand basic immune processes and immune-mediated diseases, with an emphasis on the immune system and personal medicine.
    • Assistant Professor and Member of the Faculty of Medicine - Massachusetts General Hospital Cancer Center
      Biography
        Russell Jenkins (MD, PhD) is an Assistant Professor and Member of the Faculty of Medicine, Massachusetts General Hospital Cancer Center. His research focus is understanding why immunotherapy works for some patients and not others. The Jenkins laboratory uses sophisticated tools such as 3-dimensional cultures of patients' tumors to investigate the complex and dynamic interactions between cancer cells and the immune system.

      Abstract:

      DATE: October 29, 2019

      TIME:  8:00am PDT

      Although immune-based therapies targeting the inhibitory receptors (PD-L1, PD1, and CTLA4) are proven to be effective to treat cancer, some patients do not respond, or stop responding within the first year of therapy. Identifying the underlying mechanisms associated with these variable response rates remains an important open research challenge in clinical oncology.

      Join this free webinar to learn how researchers are integrating cell sorting, RNA sequencing, ex-vivo phenotype profiling, and patient-derived xenografts to study the mechanisms of PD-L1 resistance in cancer.

       

      Who Should Attend:

      Researchers who want to integrate a multi-omics approach in their clinical studies on immune checkpoint inhibitor resistance will gain valuable insights. In addition, the webinar will benefit those who want to learn about new technologies for isolating and profiling tumor cells. 

       

      Learning Objectives:

      • Review how a multi-omics approach can be used to study the resistance mechanisms to therapies targeting immune checkpoint inhibitors.

      • Evaluate how new clinical research tools can uncover complexities of tumors and their ecosystems.  

       

      Webinars will be available for unlimited on-demand viewing after live event.

       

      LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


      Show Resources
      You May Also Like
      SEP 05, 2019 04:00 PM CEST
      C.E. CREDITS
      SEP 05, 2019 04:00 PM CEST
      DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
      NOV 18, 2019 07:00 AM PST
      C.E. CREDITS
      NOV 18, 2019 07:00 AM PST
      DATE: November 18, 2019TIME: 7:00am PST, 11:00am EST, 4:00pm CEWT How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop th...
      JUN 05, 2019 05:00 PM CEST
      C.E. CREDITS
      JUN 05, 2019 05:00 PM CEST
      DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
      AUG 27, 2019 09:00 AM PDT
      C.E. CREDITS
      AUG 27, 2019 09:00 AM PDT
      DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
      DEC 10, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      C.E. CREDITS
      DEC 10, 2019 09:00 AM PST
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
      OCT 02, 2019 11:00 AM PDT
      OCT 02, 2019 11:00 AM PDT
      DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
      Loading Comments...
      Show Resources